[Clinical experience with cefixime in the pediatric field].

Author: AiharaR, KobashiH, NishiokaA, OharaK, OkamotoT

Paper Details 
Original Abstract of the Article :
Cefixime (CFIX) was given orally to 25 children with acute bacterial infections including 13 with acute tonsillitis, 1 with acute tonsillitis and cervical lymphadenitis, 1 with acute bronchitis, 5 with bronchopneumonia and 5 with urinary tract infection. Good to excellent clinical response was obtai...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/3761542

データ提供:米国国立医学図書館(NLM)

Cefixime: A Gentle Breeze in the Desert of Pediatric Infections

Treating bacterial infections in children can be a challenging task, requiring effective and safe medications. This study examines the clinical efficacy and safety of cefixime (CFIX), an oral antibiotic, in treating various bacterial infections in children. The authors report on the clinical response and bacteriological outcomes in 25 children with conditions such as acute tonsillitis, acute bronchitis, bronchopneumonia, and urinary tract infections.

Cefixime: A Gentle Breeze in the Desert of Pediatric Infections

The study's findings suggest that cefixime is an effective and well-tolerated treatment option for various bacterial infections in children. The authors demonstrate a good to excellent clinical response in 23 out of 25 children, with bacteriological evidence of effectiveness in 14 out of 16 children who underwent testing. The study also reports minimal side effects, with only two children experiencing mild gastrointestinal discomfort or eosinophilia. The study notes that the flavor and odor of cefixime were well-accepted by children, suggesting a potentially positive patient experience.

Cefixime: A Gentle Breeze in the Desert of Pediatric Infections

This research underscores the need for effective and safe treatment options for bacterial infections in children. The study's findings provide valuable insights into the clinical utility of cefixime in treating a range of pediatric infections. This research contributes to the ongoing efforts to improve the diagnosis and treatment of pediatric infections, promoting the health and well-being of young patients.

Dr. Camel's Conclusion

Treating pediatric infections can be a delicate dance through the desert of uncertainty. This study suggests that cefixime may be a gentle breeze, offering effective and well-tolerated relief for various bacterial infections in children. While further research is always needed, this study provides valuable information for clinicians seeking safe and effective treatment options for young patients.

Date :
  1. Date Completed 1986-10-30
  2. Date Revised 2016-11-16
Further Info :

Pubmed ID

3761542

DOI: Digital Object Identifier

3761542

Related Literature

SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.